Women's Health References 35082

May 24, 2004 - Natural Products Industry INSIDER
"Women's Health" References

1. Rossouw JE et al. "Risks and benefits of estrogen plus progestin inhealthy postmenopausal women: principal results from the Women's HealthInitiative randomized controlled trial." JAMA. 288, 3:321-33, 2002. www.jama.com.

2. Haas JS et al. "Changes in the use of postmenopausal hormone therapyafter the publication of clinical trial results." Ann Intern Med.140, 3:184-8, 2004. www.annals.org.

3. Domoney CL et al. "Premenstrual syndrome and the use of alternativetherapies." Ann N Y Acad Sci. 997:330-40, 2003. www.nyas.org/publications/annals/.

4. Massart F et al. "Genetics of menopause-associated diseases." Maturitas.40, 2:103-16, 2001. www.sciencedirect.com/science/journal/03785122.

5. Thys-Jacobs S. "Micronutrients and the premenstrual syndrome: thecase for calcium." J Am Coll Nutr. 19, 2:220-7, 2000.

6. Shamberger RJ. "Calcium, magnesium, and other elements in the redblood cells and hair of normals and patients with premenstrual syndrome." BiolTrace Elem Res. 94, 2:123-9, 2003. www.humanapress.com.

7. Moyad MA. "Osteoporosis. Part III--Not just for bone loss: potentialbenefits of calcium and vitamin D for overall general health." Urol Nurs.23, 1:69-74, 2003. www.ahsl.arizona.edu/journals/ejrnl_gateway.cfm?name=Urologic%20Nursing.

8. Wyatt KM et al. "Efficacy of vitamin B-6 in the treatment ofpremenstrual syndrome: systematic review." BMJ. 318, 7195:1375-81,1999. http://bmj.com.

9. De Souza MC et al. "A synergistic effect of a daily supplement for 1month of 200 mg magnesium plus 50 mg vitamin B6 for the relief ofanxiety-related premenstrual symptoms: a randomized, double-blind, crossoverstudy." J Womens Health Gend Based Med. 9, 2:131-9, 2000. www.liebertpub.com/JWH/default1.asp.

10. Christie S et al. "Flavonoid supplement improves leg health andreduced fluid retention in pre-menopausal women in a double-blind,placebo-controlled study." Phytomedicine. 11, 1:11-7, 2004. www.urbanfischer.de/journals/frame_template.htm?/journals/phytomed/phytmed.htm.

11. Kohama T, Suzuki N. "The treatment of gynaecological disorders withPycnogenol<\#168>." Eur Bull Drug Res. 7, 2:30-2, 1999. www.europharma2000.it/Servizio%201.htm.

12. Kohama T, Suzuki N. "The treatment of gynaecological disorders withPycnogenol." Eur Bulletin Drug Res. 7, 2:30-32, 1999.

13. Dailey RK et al. "Herbal product use and menopause symptom relief inprimary care patients: a MetroNet study." J Womens Health (Larchmt).12, 7:633-41, 2003.

14. North American Menopause Society. "Treatment of menopause-associatedvasomotor symptoms: position statement of the North American MenopauseSociety." Menopause. 11, 1:11-33, 2004. www.menopausejournal.com.

15. Tesch BJ. "Herbs commonly used by women: an evidence-basedreview." Am J Obstet Gynecol. 188, 5 Suppl:S44-55, 2003. www.greenjournal.org.

16. Amato P, Marcus DM. "Review of alternative therapies for treatmentof menopausal symptoms." Climeractic. 6, 4:278-84, 2003. www.parthpub.com/climacteric.home.html.

17. Thawani V et al. "Efficacy and tolerability of herbal combination"Femnia" in perimenopausal women." The Antiseptic. 100,12:490-2, 2004.

18. van de Weijer PH, Barentsen R. "Isoflavones from red clover(Promensil) significantly reduce menopausal hot flush symptoms compared withplacebo." Maturitas. 42, 3:187-93, 2002. www.sciencedirect.com/science/journal/03785122.

19. Tice JA et al. "Phytoestrogen supplements for the treatment of hotflashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlledtrial." JAMA. 290, 2:207-14, 2003. www.jama.com.

20. Huntley AL, Ernst E. "A systematic review of herbal medicinalproducts for the treatment of menopausal symptoms." Menopause. 10,5:465-76, 2003. www.menopausejournal.com.

21. Scambia G et al. "Clinical effects of a standardized soy extract inpostmenopausal women: a pilot study." Menopause. 7, 2:105-11, 2000. www.menopausejournal.com.

22. Faure Ed et al. "Effects of a standardized soy extract on hotflushes: a multicenter, double-blind, randomized, placebo-controlledstudy." Menopause. 9, 5:329-34, 2002. www.menopausejournal.com.

23. Penotti M et al. "Effect of soy-derived isoflavones on hot flushes,endometrial thickness, and the pulsatility index of the uterine and cerebralarteries." Fertil Steril. 79, 5:1112-7, 2003.

24. Duffy R et al. "Improved cognitive function in postmenopausal womenafter 12 weeks of consumption of a soya extract containing isoflavones." PharmacolBiochem Behav. 75, 3:721-9, 2003. www.elsevier.com/locate/pharmbiochembeh.

25. Kritz-Silverstein D et al. "Isoflavones and cognitive function inolder women: the Soy and Postmenopausal Health In Aging (SOPHIA) Study." Menopause.10, 3:196-202, 2003. www.menopausejournal.com.

26. Lemay A et al. "Flaxseed dietary supplement versus hormonereplacement therapy in hypercholesterolemic menopausal women." ObstetGynecol. 100, 3:495-504, 2002. www.greenjournal.org.

27. Goss PE et al. "Effects of dietary flaxseed in women with cyclicalmastalgia." Breast Cancer Res Treat. 64:49, 2000.

28. Bagchi D et al. "Benefits of resveratrol in women's health." DrugsExp Clin Res. 27, 5-6:233-48, 2001.

29. Genazzani AD et al. "Long-term low-dose dehydroepiandrosterone oralsupplementation in early and late postmenopausal women modulates endocrineparameters and synthesis of neuroactive steroids." Fertil Steril.80, 6:1495-501, 2003.

30. Rossouw JE at al. "Risks and benefits of estrogen plus progestin inhealthy postmenopausal women: principal results from the Women's HealthInitiative randomized controlled trial." JAMA. 288, 3:321-33, 2002. www.jama.com.

31. Waters DD et al. "Effects of hormone replacement therapy andantioxidant vitamin supplements on coronary atherosclerosis in postmenopausalwomen: a randomized controlled trial." JAMA. 288, 19:2432-40, 2002. www.jama.com.

32. Lutfiyya MN et al. "HRT and vitamins C and E do not improve coronarydisease in women." J Fam Pract. 52, 2:112-4, 2003. www.jfponline.com.

33. Salonen RM et al. "Six-year effect of combined vitamin C and Esupplementation on atherosclerotic progression: the Antioxidant Supplementationin Atherosclerosis Prevention (ASAP) Study." Circulation. 107,7:947-53, 2003. http://circ.ahajournals.org.

34. Osganian SK et al. "Vitamin C and risk of coronary heart disease inwomen." J Am Coll Cardiol. 42, 2:246-52, 2003.

35. Watts GF et al. "Coenzyme Q(10) improves endothial function of thebrachial artery in Type II diabetes mellitus." Diabetologia. 45,3:420-6, 2002. http://link.springer.de/link/service/journals/00125/.

36. Singh RB et al. "Effect of coenzyme Q10 on risk of atherosclerosisin patients with recent myocardial infarction." Mol Cell Biochem.246, 1-2:75-82, 2003. www.wkap.nl.

37. Rosenfeldt F et al. "Systematic review of effect of coenzyme Q10 inphysical exercise, hypertension and heart failure." Biofactors. 18,1-4:91-100, 2003. www.iospress.nl/site/html/09516433.html.

38. Mortensen SA. "Overview on coenzyme Q10 as adjunctive therapy inchronic heart failure. Rationale, design and end-points of"Q-symbio"--a multinational trial." Biofactors. 18,1-4:79-89, 2003. www.iospress.nl/site/html/09516433.html.

39. Burke BE et al. "Randomized, double-blind, placebo-controlled trialof coenzyme Q10 in isolated systolic hypertension." South Med J. 94,11:1112-7, 2001. www.sma.org/smj/.

40. Hodgson JM et al. "Coenzyme Q10 improves blood pressure andglycaemic control: a controlled trial in subjects with type 2 diabetes." EurJ Clin Nutr. 56, 11:1137-42, 2002. www.naturesj.com/ejcn.

41. Watts GF et al. "Coenzyme Q(10) improves endothelial dysfunction ofthe brachial artery in Type II diabetes mellitus." Diabetologia. 45,3:420-6, 2002. http://link.springer.de/link/service/journals/00125/.

42. Osganian SK et al. "Dietary carotenoids and risk of coronary arterydisease in women." Am J Clin Nutr. 77, 6:1390-9, 2003. www.ajcn.org.

43. Dwyer JH et al. "Progression of carotid intima-media thickness andplasma antioxidants: the Los Angeles Atherosclerosis Study." ArteriosclerThromb Vasc Biol. 24, 2:313-9, 2004. http://atvb.ahajournals.org.

44. Sesso HD et al. "Plasma lycopene, other carotenoids, and retinol andthe risk of cardiovascular disease in women." Am J Clin Nutr. 79,1:47-53, 2004. www.ajcn.org.

45. Yochum L et al. "Dietary flavonoid intake and risk of cardiovasculardisease in postmenopausal women." Am J Epidemiol. 149, 10:943-9,1999. www.aje.oupjournals.org.

46. Huxley RR, Neil HA. "The relation between dietary flavonol intakeand coronary heart disease mortality: a meta-analysis of prospective cohortstudies." Eur J Clin Nutr. 57, 8:904-8, 2003. www.naturesj.com/ejcn.

47. Bagchi D et al. "Benefits of resveratrol in women's health." DrugsExp Clin Res. 27, 5-6:233-48, 2001.

48. Davies MJ et al. "Black tea consumption reduces total and LDLcholesterol in mildly hypercholesterolemic adults." J Nutr. 133,10:3298S-3302S, 2003. www.nutrition.org.

49. Cuevas AM et al. "Isolated soy protein improves endothelial functionin postmenopausal hypercholesterolemic women." Eur J Clin Nutr. 57,8:889-94, 2003. www.naturesj.com/ejcn.

50. Steinberg FM et al. "Soy protein with isoflavones has favorableeffects on endothelial function that are independent of lipid and antioxidanteffects in health postmenopausal women." Am J Clin Nutr. 78,1:123-30, 2003. www.ajcn.org.

51. Wagner JD et al. "Soy protein with isoflavones, but not anisoflavone-rich supplement, improves arterial low-density lipoprotein metabolismand atherogenesis." Arterioscler Thromb Vasc Biol. 23, 12:2241-6,2003. http://atvb.ahajournals.org.

52. Zhang X et al. "Soy food consumption is associated with lower riskof coronary heart disease in Chinese women." J Nutr. 133, 9:2874-8,2003. www.nutrition.org.

53. Lucas EA et al. "Soy isoflavones prevent ovariectomy-inducedatherosclerotic lesions in Golden Syrian hamster model of postmenopausalhyperlipidemia." Menopause. 10, 4:314-21, 2003. www.menopausejournal.com.

54. Jayagopal V et al. "Beneficial effects of soy phytoestrogen intakein postmenopausal women with type 2 diabetes." Diabetes Care. 25,10:1709-14, 2002. http://care.diabetesjournals.org.

55. Campbell MJ et al. "Effect of red clover-derived isolfavonesupplementation on insulin-like growth factor, lipid and antioxidant status inhealthy female volunteers: a pilot study." Eur J Clin Nutr. 58,1:173-9, 2004. www.naturesj.com/ejcn.

56. Howes JB et al. "Effects of dietary supplementation with isoflavonesfrom red clover on ambulatory blood pressure and endothelial function inpostmenopausal type 2 diabetes." Diabetes Obes Metab. 5, 5:325-32,2003. www.blackwell-synergy.com.

57. Lucas EA et al. "Flaxseed improves lipid profile without alteringbiomarkers of bone metabolism in postmenopausal women." J ClinEndocrinol Metab. 87, 4:1527-32, 2002. http://jcem.endojournals.org.

58. Lemay A et al. "Flaxseed dietary supplement versus hormonereplacement therapy in hypercholesterolemic menopausal women." ObstetGynecol. 100, 3:495-504, 2002. www.greenjournal.org.

59. Liu X et al. "Pycnogenol, French maritime pine bark extract,improves endothelial function of hypertensive patients." Life Sci.74, 7:855-62, 2004. www.sciencedirect.com/science/journal/00243205.

60. Pfeifer M et al. "Effects of a short-term vitamin D(3) and calciumsupplementation on blood pressure and parathyroid hormone levels in elderlywomen." J Clin Endocrinol Metab. 86, 4:1633-7, 2001. http://jcem.endojournals.org.

61. Gannage-Yared MH et al. "Effects of a short-term supplementation andvitamin D treatment on serum cytokines, bone markers, insulin and lipidconcentrations in healthy post-menopausal women." J Endocrinol Invest.26, 8:748-53, 2003.

62. Braam LA et al. "Beneficial effects of vitamins D and K on theelastic properties of the vessel wall in postmenopausal women: a follow-upstudy." Thromb Haemost. 91, 2:373-80, 2004.

63. Ciubotaru I et al. "Dietary fish oil decreases C-reactive protein,interlukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausalwomen on HRT." J Nutr Biochem. 14, 9:513-21, 2003. www.elsevier.com/locate/jnutbio.

64. Morelli V, Naquin C. "Alternative therapies for traditional diseasestates: menopause." Am Fam Physician. 66, 1:129-34, 2002.

65. Hu FB et al. "Fish and omega-3 fatty acid intake and risk ofcoronary heart disease in women." JAMA. 287, 14:1815-21, 2002. www.jama.com.

66. Henderson JW, Donatelle RJ. "Complementary and alternative medicineuse by women after completion of allopathic treatment for breast cancer." AlternTher Health Med. 10, 1:52-7, 2004.

67. Drisko JA et al. "The use of antioxidant therapies duringchemotherapy." Gynecol Oncol. 88, 3:434-9, 2003.www.elsevier.com/locate/issn/0090-8258.

68. Fleischauer AT et al. "Antioxidant supplements and risk of breastcancer recurrence and breast cancer-related mortality among postmenopausalwomen." Nutr Cancer. 46, 1:15-22, 2003. www.erlbaum.com/Journals/journals/NC/nc.htm.

69. Kumaraguruparan R et al. "Antioxidant profile in the circulation ofpatients with fibroadenoma and adenocarcinoma of the breast." ClinBiochem. 35, 4:275-9, 2002. www.elsevier.nl/inca/publications/store/5/2/5/4/6/3.

70. Nissen SB et al. "Intake of vitamins A, C and E from diet andsupplements and breast cancer in postmenopausal women." Cancer CausesControl. 14, 8:695-704, 2003. www.kluweronline.com/issn/0957-5243/contents.

71. Bonilla-Fernandez P et al. "Nutrional factors and breast cancer inMexico." Nutr Cancer. 45, 2:148-55, 2003. www.erlbaum.com/Journals/journals/NC/nc.htm.

72. Sato R et al. "Prospective study of carotenoids, tocopherols, andretinoid concentrations and the risk of breast cancer." Cancer EpidemiolBiomarkers Prev. 11, 5:451-7, 2002. http://cebp.aacrjournals.org.

73. Cho E et al. "Premenopausal intakes of vitamins A, C, and E, folate,and carotenoids, and risk of breast cancer." Cancer Epidemiol BiomarkersPrev. 12, 8:713-20, 2003. http://cebp.aacrjournals.org.

74. Li Z et al. "[The effects of carotenoids on the proliferation ofhuman breast cancer cell and gene expression of bcl-2.]" Zhonghua YuFang Yi Xue Za Zhi. 36, 4:254-7, 2002.

75. Sata R et al. "Prospective study of carotenoids, tocopherols, andretinoid concentrations and the risk of breast cancer." Cancer EpidemiolBiomarkers Prev. 11, 5:451-7, 2002. http://cebp.aacrjournals.org.

76. Chew BP et al. "Dietary lutein inhibits mouse mammary tumor growthby regulating angiogenesis and apoptosis." Anticancer Res. 23,4:3333-9, 2003. www.geocities.com/Athens/Rhodes/8729/iiar/iiar.htm.

77. Guthrie N et al. "Inhibition of proliferation of estrogenreceptor-negative MDA-MB-435 and positive MCF-7 human breast cancer cells bypalm oil tocotrienols and tamoxifen, alone and in combination." J Nutr.127, 3:544S-548S, 1997. www.nutrition.org.

78. Cramer DW et al. "Carotenoids, antioxidants and ovarian cancer riskon pre- and postmenopausal women." Int J Cancer. 94, 1:128-34, 2001.www3.interscience.wiley.com.

79. Mayne ST et al. "Low plasma lycopene concentration is associatedwith increased mortality in a cohort of patients with prior oral, pharynx orlarynx cancers." J Am Coll Nutr. 23, 1:34-42, 2004.

80. Wright ME et al. "Dietary carotenoids, vegetables, and lung cancerrisk in women: the Missouri women's health study (United States)." CancerCauses Control. 14, 1:85-96, 2003. www.kluweronline.com/issn/0957-5243/contents.

81. Muhlhofer A et al. "Carotenoids are decreased in biopsies fromcolorectal adenomas." Clin Nutr. 22, 1:65-70, 2003. www.harcourt-international.com/journals/clnu

82. Nkondjock A, Ghadirian P. "Dietary carotenoids and risk of coloncancer: case-control study." Int J Cancer. 110, 1:110-6, 2004. www3.interscience.wiley.com.

83. Satia-About a J et al. "Associations of micronutrients with coloncancer risk in African Americans and whites: results from the North CarolinaColon Cancer Study." Cancer Epidemiol Biomarkers Prev. 12, 8:747-54,2003. http://cebp.aacrjournals.org.

84. Harnack L et al. "Relationship of folate, vitamin B-6, vitamin B-12,and methionine intake to incidence of colorectal cancers." Nutr Cancer.43, 2:152-8, 2002. www.erlbaum.com/Journals/journals/NC/nc.htm.

85. Larsson S et al. "Dietary folate intake and incidence of ovariancancer: the Swedish Mammography Cohort." J Natl Cancer Inst. 96,5:396-402, 2004.

86. Feigelson HS et al. "Alcohol, folate, methionine, and risk ofincident breast cancer in the American Cancer Prevention Study II NutritionCohort." Cancer Epidemiol Biomarkers Prev. 12, 2:161-4, 2003. http://cebp.aacrjournals.org.

87. O'Kelly J, Koeffler HP. "Vitamin D analogs and breast cancer." RecentResults Cancer Res. 164:333-48, 2003.

88. Friedrich M et al. "Analysis of the vitamin D system in cervicalcarcinomas, breast cancer and ovarian cancer." Recent Results Cancer Res.164:239-46, 2003.

89. Punj V et al. "Effect of vitamin D analog (1alpha hydroxy D5)immunoconjugated to Her-2 antibody on breast cancer." Int J Cancer.108, 6:922-9, 2004. www3.interscience.wiley.com.

90. Sieja K, Talerczyk M. "Selenium as an element in the treatment ofovarian cancer in women receiving chemotherapy." Gynecol Oncol. 93,2:320-7, 2004.

91. Lee DH et al. "Heme iron, zinc, alcohol consumption, and coloncancer: Iowa Women's Health Study." J Natl Cancer Inst. 96, 5:403-7,2004.

92. Tou J, Thompson LU. "Exposure to flaxseed or its lignan componentduring different developmental stages influences rat mammary glandstructures." Carcinogenesis. 20, 9:1831-5, 1999. http://carcin.oupjournals.org.

93. Chen J et al. "Exposure to flaxseed or its purified lignan duringsuckling inhibits chemically induced rat mammary tumorigenesis." ExpBiol Med (Maywood).. 228, 8:951-8, 2003.

94. Chen J et al. "Dietary flaxseed inhibits human breast cancer growthand metastasis and downregulates expression of insulin-like growth factor andepidermal growth factor receptor." Nutr Cancer. 43, 2:187-92, 2002. www.erlbaum.com/Journals/journals/NC/nc.htm.

95. Thompson LU, Li T et al. "Biological effects of dietary flaxseed inpatients with breast cancer." Breast Cancer Res Treat. 64:50, 2000.

96. Yamamoto S et al. "Soy, isoflavones, and breast cancer risk inJapan." J Natl Cancer Inst. 95, 12:906-13, 2003.

97. Chen WF et al. "Inhibitory actions of genistein in human breastcancer (MCF-7) cells." Biochim Biophys Acta. 1638, 2:187-96, 2003. www.elsevier.nl/locate/bba

98. Li Y et al. "Induction of apoptosis in breast cancer cellsMDA-MB-231 by genistein." Oncogene 18, 20:3166-72, 1999.

99. Cabanes A et al. "Prepubertal estradiol and genistein exposuresup-regulate BRCA1 mRNA and reduce mammary tumorigenesis." Carcinogenesis.25, 5:741-8, 2004. http://carcin.oupjournals.org.

100. Guo JY et al. "Dietary soy isoflavones and estrone protectovariectomized EralphaKO and wild-type mice from carcinogen-induced coloncancer." J Nutr. 134, 1:179-82, 2004. www.nutrition.org.

101. Macdonald HM et al. "Nutritional associations with bone loss duringthe menopausal transition: evidence of a beneficial effect of calcium, alcohol,and fruit and vegetable nutrients and of a detrimental effect of fattyacids." Am J Clin Nutr. 79, 1:155-65, 2004. www.ajcn.org.

102. Wengreen HJ et al. "Dietary protein intake and risk of osteoporotichip fracture in elderly residents of Utah." J Bone Miner Res. 19,4:537-45, 2004. www.jbmr-online.org.

103. Brown JP et al. "2002 clinical practice guidelines for thediagnosis and management of osteoporosis in Canada." CMAJ. 167, 10Suppl. S1-34, 2002.

104. Nguyen TV et al. "Osteoporosis: underrated, underdiagnosed andundertreated." Med J Aust. 180, 5 Suppl:S18-22, 2004. www.mja.com.au

105. Moyad MA. "The potential benefits of dietary and/or supplementalcalcium and vitamin D." Urol Oncol. 21, 5:384-91, 2003.

106. Shea B et al. "Calcium supplementation on bone loss inpostmenopausal women." Cochrane Database Syst Rev. 1:CD004526, 2004.www.medlib.com/spi/cdsr.htm.

107. Torres A et al. "Treatment with intermittent calcitrol and calciumreduces bone loss after renal transplantation." Kidney Int. 65,2:705-12, 2004.

108. Feskanich D et al. "Calcium, vitamin D, milk consumption, and hipfractures: a prospective study among postmenopausal women." Am J ClinNutr. 77, 2:504-11, 2003. www.ajcn.org.

109. Bischoff-Ferrari HA et al. "[Effect of vitamin D on muscle strengthand relevance in regard to osteoporosis prevention.]" Z Rheumatol.62, 6:518-21, 2003.

110. Braam LA et al. "Vitamin K1 supplementation retards bone loss inpostmenopausal women between 50 and 60 years of age." Calcif Tissue Int.73, 1:21-6, 2003. http://link.springer.de/link/service/journals/00223/

111. Hirano J, Ishii Y. "Effects of vitamin K2, vitamin D, and calciumon the bone metabolism of rats in the growth phase." J Orthop Sci.7, 3:364-9, 2002.

112. Hidaka T et al. "Treatment for patients with postmenopausalosteoporosis who have been placed on HRT and show a decrease in bone mineraldensity: effects of concomitant administration of vitamin K(2)." J BoneMiner Metab. 20, 4:235-9, 2002. http://link.springer.de/link/service/journals/00774/

113. Dhonukshe-Rutten RA et al. "Vitamin B-12 status is associated withbone mineral content and bone mineral density in frail elderly women but not inmen." J Nutr. 133, 3:801-7, 2003. www.nutrition.org.

114. Maggio D et al. "Market decrease in plasma antioxidants in agedosteoporotic women: results of a cross-sectional study." J ClinEndocrinol Metab. 88, 4:1523-7, 2003. http://jcem.endojournals.org.

115. Bendich A. "Micronutrients in women's health and immunefunction." Nutrition. 17, 10:858-67, 2001. www.elsevier.com/locate/nut.

116. Turan B et al. "Selenium combined with vitamin E and vitamin Crestores structural alterations of bones in heparin-induced osteoporosis." ClinRheumatol. 22, 6:432-6, 2003. http://link.springer.de/link/service/journals/10067

117. Kaptoge S et al. "Effects of dietary nutrients and food groups onbone loss from the proximal femur in men and women in the 7th and 8th decades ofage." Osteoporos Int. 14, 5:418-28, 2003. www.link.springer.de/link/service/journals/00198

118. Setchell KD, Lydeking-Olsen E. "Dietary phytoestrogens and theireffect on bone: evidence from in vitro and in vivo, human observational, anddietary intervention studies." Am J Clin Nutr. 78, 3Suppl:593S-609S, 2003. www.ajcn.org.

119. Chen YM et al. "Soy isoflavones have a favorable effect on boneloss in Chinese postmenopausal women with lower bone mass: a double-blind,randomized, controlled trial" J Clin Endocrinol Metab. 88,10:4740-7, 2003. http://jcem.endojournals.org.

120. Paik MK et al. "Genistein may prevent cadmium-induced bone loss inovariectomized rats." J Med Food. 6, 4:337-43, 2003. www.liebertpub.com.

121. Morabito N et al. "Effects of genistein and hormone-replacementtherapy on bone loss in early postmenopausal women: a randomized double-blindplacebo-controlled study." J Bone Miner Res. 17, 10:1904-12, 2002. www.jbmr-online.org.

122. Ho SC et al. "Soy protein consumption and bone mass in earlypostmenopausal Chinese women." Osteoporos Int. 14, 10:835-42, 2003. www.link.springer.de/link/service/journals/00198

123. Harding JF. "Nutrition and growth before birth." Asia Pac JClin Nutr. 12 Suppl:S28, 2003.

124. Villar J et al. "Nutritional interventions during pregnancy for theprevention or treatment of maternal morbidity and preterm delivery: an overviewof randomized controlled trials." J Nutr. 133, 5, Suppl2:1606S-1625S, 2003. www.nutrition.org.

125. Mungen E. "Iron supplementation in pregnancy." J Perinat Med.31, 5:420-6, 2003.

126. Christian P et al. "Supplementation with micronutrients in additionto iron and folic acid does not further improve the hematologic status ofpregnant women in rural Nepal." J Nutr. 133, 11:3492-8, 2003. www.nutrition.org.

127. Szarfarc SC et al. "Relative effectiveness of iron bis-glycinatechelate (Ferrochel) and ferrous sulfate in the control of iron deficiency inpregnant women." Arch Latinoam Nutr. 51, 1 Suppl 1:42-7, 2001.

128. Palot M. et al. "[Prevention of deep vein thrombosis andpreeclampsia. Therapeutic possibilities.]" Ann Med Interne (Paris).154, 5-6:354-60, 2003.

129. Crowther CA et al. "Calcium supplementation in nulliparous womenfor the prevention of pregnancy-induced hypertension, preeclampsia and pretermbirth: an Australian randomized trial. FRACOG and the ACT Study Group." AustN Z J Obstet Gynaecol. 39, 1:12-8, 1999.

130. Bilodeau JF, Hubel CA. "Current concepts in the use of antioxidantsfor the treatment of preeclampsia." J Obstet Gynaecol Can. 25,9:742-50.

131. Chappell LC et al. "Vitamin C and E supplementation in women atrisk of preeclampsia is associated with changes in indices of oxidative stressand placental function." Am J Obstet Gynecol. 187, 3:777-84, 2002. www.mosby.com/Mosby/Periodicals/Medical/AJOG/ob.html

132. Lee BE et al. "Influence of maternal serum levels of vitamins C andE during the second trimester on birth weight and length." Eur J ClinNutr. Mar 31, 2004. Epub ahead of print. www.naturesj.com/ejcn.

133. Serdar Z et al. "Lipid and protein oxidation and antioxidantfunction in women with mild and severe preeclampsia." Arch GynecolObstet. 268, 1:19-25, 2003.

134. Williams MA et al. "Plasma carotenoids, retinol, tocopherols, andlipoproteins in preeclamptic and normotensive pregnant Zimbabwean women." AmJ Hypertens. 16, 8:665-72, 2003.

135. Williams MA et al. "Omega-3 fatty acids in maternal erythrocytesand risk of preeclampsia." Epidemiology. 6, 3:232-7, 1995. www.epidem.com.

136. Mattar F, Sibai BM. "Prevention of preeclampsia." SeminPerinatol. 23, 1:58-64, 1999.

137. Makrides M, Gibson RA. "Long-chain polyunsaturated fatty acidrequirements during pregnancy and lactation." Am J Clin Nutr. 71, 1Suppl:307S-11S, 2000. www.ajcn.org.

138. Dunstan JA et al. "Fish oil supplementation in pregnancy modifiesneonatal allergen-specific immune responses and clinical outcomes in infants athigh risk of atophy: a randomized, controlled trial." J Allergy ClinImmunol. 112, 6:1178-84, 2003.

139. Joshi S et al. "Fish oil supplementation of rats during pregnancyreduces adult disease risks in their offspring." J Nutr. 133,10:3170-4, 2003. www.nutrition.org.